Israel state records י"ב באדר התשס"ו March 12, 2006



Download 0.86 Mb.
Page2/13
Date06.06.2017
Size0.86 Mb.
#20054
1   2   3   4   5   6   7   8   9   ...   13

[57] A DNA coding for premersacidin having the amino acid sequence in FIG. 2 as shown in the specification from amino acid No. 1 through 68 (SEQ ID NO: 1).

__________





117425

[21][11]

וריאנטים של פולפפטיד GAS6, חומצות גרעין המקודדות להם, תכשירים המכילים וריאנטים כאלה, שיטה להכנתם והשימוש בהם להגברת השרדות, התרבות או תהמיינות של תאים המכילים רצפטור Rse או רצפטור Mer


GAS6 POLYPEPTIDE VARIANTS, NUCLEIC ACIDS ENCODING THEM, COMPOSITIONS CONTAINING SUCH VARIANTS, METHOD FOR THEIR PREPARATION AND USE THEREOF IN ENHANCING SURVIVAL, PROLIFERATION OR DIFFERENTIATION OF CELLS COMPRISING THE RSE RECEPTOR OR MER RECEPTOR


[54]




10.03.1996

[22]




US

[33]

10.03.1995

[32]

08/402253

[31]




US




10.05.1995




08/438861




Int. Cl.7 A61K 038/18, C07K 014/46, 014/475, 014/745, C12N 005/10, 015/12, 015/19, 015/63

[51]




GENENTECH, INC., U.S.A.

[71]

ש. הורוביץ ושות',

רחוב אחד העם 31 , ת.ד. 2499, תל אביב



S. HOROWITZ & CO.,

31 AHAD HA'AM STREET

P.O.B. 2499

TEL AVIV 61024



[74]




[57] Gas6 polypeptide which lacks one or more glutmatic acid residues from the A domain of native gas6 (growth arrest-specific gene 6), native gas6 having the amino acid sequence as set out in Figure 2 of the specification and said gas6 polypeptode being capable of binding the Rse receptor or to the Mer receptor.


__________




121535

[21][11]

מבנה של מוליך על


SUPERCONDUCTIVE STRUCTURE


[54]




12.08.1997

[22]




US

[33]

03.09.1996

[32]

707348

[31]

Int. Cl.7 H01L 029/165

[51]




INTERNATIONAL BUSINESS MACHINES CORPORATION, U.S.A.

[71]

ריינהולד כהן ושותפיו,

רחוב אחד העם 21 , ת.ד. 4060, תל אביב



REINHOLD COHN AND PARTNERS,

21 AHAD HA'AM ST.,

P.O.BOX 4060,

TEL AVIV 61040



[74]




[57] A structure for carrying superconducting current comprising: a substrate; a first epitaxial P type semiconductor layer (33) for transporting holes; a second epitaxial barrier layer (30) positioned on said first layer, said barrier layer restricting the recombination of electrons while permitting coulomb force attraction between electrons and said holes to form electron-hole pairs; and a third epitaxial N type semiconductor layer (25) for transporting said electrons.


__________





121916

[21][11]

שיטה לשינוי צורת האף


METHOD FOR CHANGING THE NOSE PROFILE


[54]




07.10.1997

[22]

Int. Cl.7 A61B 017/24

[51]

אפרון רוזן, תל-אביב

EFRON ROZAN

[71]

אפרון רוזן,

רחוב משה קול8/16, תל-אביב



EFRON ROZAN,

MOSHE KOL 8 APP.16

TEL AVIV 69626


[74]




[57] A tool for changing the nose profile made in the form of pincers consisting of a handle (1) and two jaws (2) with a knife installed on one of the jaws making it possible to cut out a fragment of the nasal septum cartilaginous portion as the jaws close in, such that there is a space between working elements in the zone situated between the jaws and the handle, said space intended for placing the nasal septum cartilaginous portion, said knife cutting edge (7) is made closed and has configuration and dimensions of a fragment to be removed of the nasal septum cartilaginous portion.



__________


122206

[21][11]

תכשיר רוקחות להבעה גנטית המכיל ווקטור של וירוס הקשור באדינו


PHARMACEUTICAL COMPOSITION FOR GENE EXPRESSION CONTAINING AN ADENO-ASSOCIATED VIRUS VECTOR


[54]




05.06.1996

[22]




US

[33]

07.06.1995

[32]

08/487005

[31]

Int. Cl.7 A61K 048/00, C12N 005/06, 015/86

[51]




UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, U.S.A.

[71]




WO/1997/040272

[87]

וולף, ברגמן וגולר,

רחוב קרן היסוד 19ב' , ת.ד. 1352, ירושלים



WOLFF, BREGMAN AND GOLLER,

19B KEREN HAYESOD ST.

P.O.B. 1352,

JERUSALEM 91013



[74]




[57] A pharmaceutical composition for expressing a gene product in the muscle tissue of an animal, comprising a recombinant adeno-associated virus (AAV) vector formulated for administration to the muscle tissue of said animal, wherein said vector comprises a non-AAV gene of interest ligated into an AAV vector genome as active ingredient therein, and said muscle tissue is other than cardiac muscle.

__________





123434

[21][11]

ווסת זרם עצמי לממטרה זעירה


FLOW SELF-REGULATING MICRO-SPRINKLER SUPPORT


[54]




24.02.1998

[22]




ES

[33]

25.02.1997

[32]

9700395

[31]

Int. Cl.7 A01G 015/00

[51]




PLASTICOS MONDRAGON S.A., SPAIN

[71]




JUAN VIVES CLAVEL

[72]

יצחק דה בוטון,

רחוב אנוסי משהד 7 , ת.ד. 29157, ירושלים



ITZHAK DE BOTTON,

7 ANUSEI MISHAD

P.O.B. 29157

JERUSALEM 91293



[74]



[57] A support for a flow self-regulating micro-sprinkler, essentially characterized in that it is particularly applicable to micro-diffusers and in that the said support is constituted by an ovoidal body (1) having a flat base which is provided in its interior with a cylindrical stepped hose from said base of two different diameters, the one for the input being larger, which permits the housing in its interior, which is advantageously splined, of an end of the stake (3) for attachment to the ground, with the possibility of use of the two more frequently used; said ovoidal body being provided with a lateral extension (4) which joins it inseparably to a tube (5) for input of the self-regulating micro-sprinkler.




__________




124834

[21][11]

שיטה להכנת קולגין מסוג II


METHOD FOR PREPARATION OF TYPE II COLLAGEN


[54]




03.01.1997

[22]




US

[33]

05.01.1996

[32]

60/009723

[31]

Int. Cl.7 C07K 014/78, C12P 021/06

[51]




AUTOIMMUNE, INC., U.S.A.

[71]




WO/1997/025435

[87]

סנפורד ט. קולב ושות',,

שער הגיא 4, מרמורק , ת.ד. 2273, רחובות



SANFORD T.COLB & CO.,

P.O.B. 2273,

REHOVOT


[74]










[57] Method of facilitating the removal of perichondrial membrane from vertebrate cartilage tissue containing unseparated perichondrial membrane comprising contacting said cartilage with an acidic solution containing an acid protease under agitation for a period of time sufficient to digest or loosen said perichondrial membrane from said cartilage.

__________





124913

[21][11]

טבליות פרמצווטיות המכילות פאמציקלוביר בריכוז גבוהה


PHARMACEUTICAL TABLETS CONTAINING FAMCICLOVIR IN HIGH CONCENTRATIONS


[54]




13.01.1997

[22]




GB

[33]

16.01.1996

[32]

9600847.9

[31]

Int. Cl.7 A61K 009/20, 031/52, A61P 031/12, C07D 473/18, 473/32

[51]




NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., BERMUDA

[71]




WO/1997/025990

[87]

לוצאטו את לוצאטו,

גן תעשיה, עומר , ת.ד. 5352, באר שבע



LUZZATTO & LUZZATTO,

P.O.B. 5352

BEER-SHEVA 84965


[74]




[57] A pharmaceutical tablet wherein famciclovir is the active ingredient and wherein the percentage of famciclovir by weight in the tablet is 85% or greater.

__________





125271

[21][11]

מתג רשת עבור חסימת ראש התור


NETWORK SWITCH FOR HEAD OF LINE BLOCKING


[54]




08.07.1998

[22]

Int. Cl.7 H04L 012/56

[51]

גלילאו טכנולוגיות בע"מ, ד.נ. מישגב

GALILEO TECHNOLOGY LTD.

[71]

איתן, פרל, לצר וכהן צדק,

רחוב שנקר 7 , ת.ד. 12688, הרצליה



EITAN, PEARL, LATZER AND COHEN ZEDEK,

P.O.B. 12688,

HERZLIYA 46733


[74]




[57] A network switch (50) comprising: a plurality of output ports (16) each having a control unit associated therewith; at least one input port (18) for receiving incoming data destined for various ones of said output ports; and

a queuing manager (12) for directing said incoming data to their destination output ports; wherein each control unit comprises: an output queue (66) for storing said incoming data destined for its associated output port; a fullness/emptiness sensor (64) for sensing when said output queue reaches a fullness or an emptiness state; and a head of line (HOL) mask (52 ) connected to the output of said sensor, for preventing queuing of said incoming data to said output queue when said sensor senses said fullness state and for enabling queuing when said sensor senses said emptiness state.



__________





125913

[21][11]

תרכובת תרופתי מורכב של תולדות בנזוילגואנידין כמעכב משאבת שחלוף Na+/H+ ותרופה לטיפול במחלות לב


PHARMACEUTICAL COMBINATION PREPARATION OF A BENZOYLGUANIDINE DERIVATIVE INHIBITOR OF THE NA+/H + EXCHANGER AND A MEDICAMENT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES


[54]




24.08.1998

[22]




DE

[33]

27.08.1997

[32]

19737224.4

[31]

Int. Cl.7 A61K 031/155, 045/06, A61P 009/00, C07C 279/22

[51]




SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY

[71]

איתן, פרל, לצר וכהן צדק,

רחוב שנקר 7 , ת.ד. 12688, הרצליה



EITAN, PEARL, LATZER AND COHEN ZEDEK,

P.O.B. 12688,

HERZLIYA 46733


[74]





Download 0.86 Mb.

Share with your friends:
1   2   3   4   5   6   7   8   9   ...   13




The database is protected by copyright ©ininet.org 2024
send message

    Main page